Status:
UNKNOWN
Diffuse Noxious Inhibitory Controls (DNIC): Nociceptive Modulation and Interaction With Neurocognitive Performance in Chronic Pain
Lead Sponsor:
Vrije Universiteit Brussel
Collaborating Sponsors:
Research Foundation Flanders
Conditions:
Fibromyalgia
Whiplash
Eligibility:
All Genders
18-65 years
Brief Summary
Diffuse noxious inhibitory control In order to quantify central sensitization in chronic pain patients, the Diffuse Noxious Inhibitory Control (DNIC) model has been used frequently. DNIC relies on pai...
Eligibility Criteria
Inclusion
- 30 FM group: comply with the diagnostic criteria for FM as defined by the American College of Rheumatology.
- 30 WAD group: comply with the criteria of the Quebec Task Force (grade I to III)
- 40 healthy pain-free control subjects
- Dutch speaking
- aged between 18 and 65 years.
Exclusion
- FM patients reporting a history of a whiplash trauma
- WAD patients fulfilling the diagnostic criteria for FM
- healthy control subjects cannot suffer any pain complaints
- cannot be pregnant or until 1 year postnatal
- asked to stop analgesics 48 hours prior to study participation, not to undertake physical exertion, and to refrain from consuming caffeine, alcohol or nicotine on the day of the experiment.
Key Trial Info
Start Date :
July 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2011
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01172795
Start Date
July 1 2010
End Date
August 1 2011
Last Update
July 30 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vrije Universiteit Brussel
Brussels, Brussels Capital, Belgium, 1050